Literature DB >> 18227185

Genetic structures at the origin of acquisition of the beta-lactamase bla KPC gene.

Thierry Naas1, Gaelle Cuzon, Maria-Virginia Villegas, Marie-Frédérique Lartigue, John P Quinn, Patrice Nordmann.   

Abstract

Genetic structures surrounding the carbapenem-hydrolyzing Ambler class A bla KPC gene were characterized in several KPC-positive Klebsiella pneumoniae and Pseudomonas aeruginosa strains isolated from the United States, Colombia, and Greece. The bla KPC genes were associated in all cases with transposon-related structures. In the K. pneumoniae YC isolate from the United States, the beta-lactamase bla KPC-2 gene was located on a novel Tn3-based transposon, Tn4401. Tn4401 was 10 kb in size, was delimited by two 39-bp imperfect inverted repeat sequences, and harbored, in addition to the beta-lactamase bla KPC-2 gene, a transposase gene, a resolvase gene, and two novel insertion sequences, ISKpn6 and ISKpn7. Tn4401 has been identified in all isolates. However, two isoforms of this transposon were found: Tn4401a was found in K. pneumoniae YC and K. pneumoniae GR from the United States and Greece, respectively, and differed by a 100-bp deletion, located just upstream of the bla KPC-2 gene, compared to the sequence of Tn4401b, which was found in the Colombian isolates. In all isolates tested, Tn4401 was flanked by a 5-bp target site duplication, the signature of a recent transposition event, and was inserted in different open reading frames located on plasmids that varied in size and nature. Tn4401 is likely at the origin of carbapenem-hydrolyzing beta-lactamase KPC mobilization to plasmids and its further insertion into various-sized plasmids identified in nonclonally related K. pneumoniae and P. aeruginosa isolates.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18227185      PMCID: PMC2292522          DOI: 10.1128/AAC.01451-07

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  33 in total

1.  Plasmid-mediated imipenem-hydrolyzing enzyme KPC-2 among multiple carbapenem-resistant Escherichia coli clones in Israel.

Authors:  Shiri Navon-Venezia; Inna Chmelnitsky; Azita Leavitt; Mitchell J Schwaber; David Schwartz; Yehuda Carmeli
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

2.  Plasmid-mediated carbapenem-hydrolysing beta-lactamase KPC-2 in carbapenem-resistant Serratia marcescens isolates from Hangzhou, China.

Authors:  Rong Zhang; Hong Wei Zhou; Jia Chang Cai; Gong-Xiang Chen
Journal:  J Antimicrob Chemother       Date:  2007-01-24       Impact factor: 5.790

3.  First identification of Pseudomonas aeruginosa isolates producing a KPC-type carbapenem-hydrolyzing beta-lactamase.

Authors:  Maria Virginia Villegas; Karen Lolans; Adriana Correa; Juan Nicolas Kattan; Jaime A Lopez; John P Quinn
Journal:  Antimicrob Agents Chemother       Date:  2007-01-29       Impact factor: 5.191

4.  Occurrence and characterization of carbapenemase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program (2000-2004).

Authors:  Lalitagauri M Deshpande; Ronald N Jones; Thomas R Fritsche; Helio S Sader
Journal:  Microb Drug Resist       Date:  2006       Impact factor: 3.431

5.  Plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in Klebsiella pneumoniae isolate from Greece.

Authors:  Gaelle Cuzon; Thierry Naas; Marie Claude Demachy; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2007-12-03       Impact factor: 5.191

Review 6.  Carbapenemases: the versatile beta-lactamases.

Authors:  Anne Marie Queenan; Karen Bush
Journal:  Clin Microbiol Rev       Date:  2007-07       Impact factor: 26.132

7.  Evolution of antimicrobial resistance among Pseudomonas aeruginosa, Acinetobacter baumannii and Klebsiella pneumoniae in Brooklyn, NY.

Authors:  David Landman; Simona Bratu; Sandeep Kochar; Monica Panwar; Manoj Trehan; Mehmet Doymaz; John Quale
Journal:  J Antimicrob Chemother       Date:  2007-05-09       Impact factor: 5.790

8.  Emergence of KPC-2 and KPC-3 in carbapenem-resistant Klebsiella pneumoniae strains in an Israeli hospital.

Authors:  Azita Leavitt; Shiri Navon-Venezia; Inna Chmelnitsky; Mitchell J Schwaber; Yehuda Carmeli
Journal:  Antimicrob Agents Chemother       Date:  2007-06-11       Impact factor: 5.191

9.  Crystal structure of KPC-2: insights into carbapenemase activity in class A beta-lactamases.

Authors:  Wei Ke; Christopher R Bethel; Jodi M Thomson; Robert A Bonomo; Focco van den Akker
Journal:  Biochemistry       Date:  2007-04-19       Impact factor: 3.162

10.  Detection and spread of Escherichia coli possessing the plasmid-borne carbapenemase KPC-2 in Brooklyn, New York.

Authors:  Simona Bratu; Steven Brooks; Sibte Burney; Sandeep Kochar; Jyoti Gupta; David Landman; John Quale
Journal:  Clin Infect Dis       Date:  2007-02-21       Impact factor: 9.079

View more
  195 in total

1.  First report of a clinical, multidrug-resistant Enterobacteriaceae isolate coharboring fosfomycin resistance gene fosA3 and carbapenemase gene blaKPC-2 on the same transposon, Tn1721.

Authors:  Gang Li; Ying Zhang; Dexi Bi; Pinghua Shen; Fuqi Ai; Hong Liu; Yueru Tian; Yiming Ma; Bei Wang; Kumar Rajakumar; Hong-Yu Ou; Xiaofei Jiang
Journal:  Antimicrob Agents Chemother       Date:  2014-11-03       Impact factor: 5.191

2.  Molecular characteristics of KPC-producing Enterobacteriaceae at the early stage of their dissemination in Poland, 2008-2009.

Authors:  Anna Baraniak; Anna Grabowska; Radosław Izdebski; Janusz Fiett; Małgorzata Herda; Katarzyna Bojarska; Dorota Żabicka; Marta Kania-Pudło; Grazyna Młynarczyk; Zofia Żak-Puławska; Waleria Hryniewicz; Marek Gniadkowski
Journal:  Antimicrob Agents Chemother       Date:  2011-09-19       Impact factor: 5.191

3.  Molecular characterization of newly emerged blaKPC-2-producing Klebsiella pneumoniae in Singapore.

Authors:  Michelle N D Balm; Grace Ngan; Roland Jureen; Raymond T P Lin; Jeanette Teo
Journal:  J Clin Microbiol       Date:  2011-11-23       Impact factor: 5.948

4.  Role of ISKpn7 and deletions in blaKPC gene expression.

Authors:  Thierry Naas; Gaelle Cuzon; Ha-Vy Truong; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2012-06-25       Impact factor: 5.191

5.  Complete nucleotide sequence of KPC-3-encoding plasmid pKpQIL in the epidemic Klebsiella pneumoniae sequence type 258.

Authors:  Azita Leavitt; Inna Chmelnitsky; Yehuda Carmeli; Shiri Navon-Venezia
Journal:  Antimicrob Agents Chemother       Date:  2010-08-09       Impact factor: 5.191

6.  Emergence of KPC-producing Pseudomonas aeruginosa in the United States.

Authors:  Laurent Poirel; Patrice Nordmann; Emilie Lagrutta; Timothy Cleary; L Silvia Munoz-Price
Journal:  Antimicrob Agents Chemother       Date:  2010-04-26       Impact factor: 5.191

7.  Complete nucleotide sequence of Klebsiella pneumoniae multidrug resistance plasmid pKP048, carrying blaKPC-2, blaDHA-1, qnrB4, and armA.

Authors:  Yan Jiang; Dongliang Yu; Zeqing Wei; Ping Shen; Zhihui Zhou; Yunsong Yu
Journal:  Antimicrob Agents Chemother       Date:  2010-06-14       Impact factor: 5.191

8.  Susceptibility profiles, molecular epidemiology, and detection of KPC-producing Escherichia coli isolates from the New York City vicinity.

Authors:  David Landman; Carl Urban; Martin Bäcker; Paul Kelly; Neha Shah; Elizabeth Babu; Simona Bratu; John Quale
Journal:  J Clin Microbiol       Date:  2010-10-06       Impact factor: 5.948

Review 9.  Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions.

Authors:  L S Tzouvelekis; A Markogiannakis; M Psichogiou; P T Tassios; G L Daikos
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

10.  CG258 Klebsiella pneumoniae isolates without β-lactam resistance at the onset of the carbapenem-resistant Enterobacteriaceae epidemic in New York City.

Authors:  Brandon Eilertson; Liang Chen; Audrey Li; Kalyan D Chavda; Bhakti Chavda; Barry N Kreiswirth
Journal:  J Antimicrob Chemother       Date:  2019-01-01       Impact factor: 5.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.